Start of Main Content
Case
Reintroduce Thalidomide? (A)
Author(s)
In the 1960s, Thalidomide, a popular new drug considered to be safe and effective, was revealed to cause severe nerve damage and birth defects in new-born infants, prompting health officials to ban the use of the drug and tighten overall restrictions on new drugs and drug use. Twenty years later, after recognizing the positive effects of Thalidomide when treating patients with leprosy and its potential role in treatment of certain types of cancer and cases of HIV/AIDS, the Celgene Corporation would be forced to contend with stringent FDA regulations, liability concerns, public skepticism, and poor mass media portrayal in order to secure the drug's approval.
Date Published:
10/01/2006
Discipline:
Biotechnology;Management;Manufacturing;Strategy
Key Concepts:
Thalidomide, Healthcare, Pharmaceuticals, Patient Advocacy, Non-Government Organizations, Global
Citations:
Diermeier, Daniel, Jason Hermitage, Shail Thaker, Justin Heinze. Reintroduce Thalidomide? (A). 5-104-003(A) (KEL058).